These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19032760)

  • 1. Prediction of specificity-determining residues for small-molecule kinase inhibitors.
    Caffrey DR; Lunney EA; Moshinsky DJ
    BMC Bioinformatics; 2008 Nov; 9():491. PubMed ID: 19032760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical genomic and proteomic methods for determining kinase inhibitor selectivity.
    Krishnamurty R; Maly DJ
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):652-66. PubMed ID: 18045078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
    Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A
    Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase inhibitors: structural insights into selectivity.
    Thaimattam R; Banerjee R; Miglani R; Iqbal J
    Curr Pharm Des; 2007; 13(27):2751-65. PubMed ID: 17897021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
    Christmann-Franck S; van Westen GJ; Papadatos G; Beltran Escudie F; Roberts A; Overington JP; Domine D
    J Chem Inf Model; 2016 Sep; 56(9):1654-75. PubMed ID: 27482722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural approaches to obtain kinase selectivity.
    Norman RA; Toader D; Ferguson AD
    Trends Pharmacol Sci; 2012 May; 33(5):273-8. PubMed ID: 22503441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding.
    Sheinerman FB; Giraud E; Laoui A
    J Mol Biol; 2005 Oct; 352(5):1134-56. PubMed ID: 16139843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-guided selection of specificity determining positions in the human Kinome.
    Moll M; Finn PW; Kavraki LE
    BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):431. PubMed ID: 27556159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections.
    Qin Z; Zhang J; Xu B; Chen L; Wu Y; Yang X; Shen X; Molin S; Danchin A; Jiang H; Qu D
    BMC Microbiol; 2006 Nov; 6():96. PubMed ID: 17094812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling bone marrow toxicity using kinase structural motifs and the inhibition profiles of small molecular kinase inhibitors.
    Olaharski AJ; Bitter H; Gonzaludo N; Kondru R; Goldstein DM; Zabka TS; Lin H; Singer T; Kolaja K
    Toxicol Sci; 2010 Nov; 118(1):266-75. PubMed ID: 20810542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
    Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
    J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of Amino Acid Residues Responsible for Specific Interaction of Protein Kinases with Small Molecule Inhibitors].
    Karasev DA; Veselovsky AV; Lagunin AA; Filimonov DA; Sobolev BN
    Mol Biol (Mosk); 2018; 52(3):555-564. PubMed ID: 29989588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding kinase selectivity through energetic analysis of binding site waters.
    Robinson DD; Sherman W; Farid R
    ChemMedChem; 2010 Apr; 5(4):618-27. PubMed ID: 20183853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring sequence-structure relationships in the tyrosine kinome space: functional classification of the binding specificity mechanisms for cancer therapeutics.
    Verkhivker GM
    Bioinformatics; 2007 Aug; 23(15):1919-26. PubMed ID: 17537753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.